Latest Breaking News On - Once daily treatment - Page 1 : comparemela.com

BioCryst Pharmaceuticals, Inc : BioCryst Reports First Quarter 2024 Financial Results and Provides Business Update

BioCryst Pharmaceuticals, Inc : BioCryst Reports First Quarter 2024 Financial Results and Provides Business Update
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesHelen thackrayJohn bluthCharlie gayerJon stonehouseBiocryst pharmaceuticals incInternational society for pharmacoeconomicsBiocryst pharmaceuticalsOutcomes researchExchange commissionCryst pharmaceuticalsOnce daily treatmentHereditary angioedemaAnnual reportQuarterly reportsCurrent reports

BioCryst Reports Third Quarter 2023 Financial Results and Provides Business Update

BioCryst Reports Third Quarter 2023 Financial Results and Provides Business Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJohn bluthJon stonehouseCharlie gayerDevelopment rd dayProgram updatesExchange commissionDiscovery centerBiocryst pharmaceuticals incBiocryst pharmaceuticalsCryst pharmaceuticalsOnce daily treatmentHereditary angioedemaFinancial measuresWall streetAnnual report

Oculis Holding (OCS) Reports OCS-01 Met Both Primary Endpoints in Phase 3 OPTIMIZE Trial

Oculis Holding (OCS) Reports OCS-01 Met Both Primary Endpoints in Phase 3 OPTIMIZE Trial
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Michael korenfeldSylvia cheungLifesci advisorscorey davisEric donnenfeldOculis holding ag nasdaqOculis holdingExchange commissionShow potentialOnce daily treatmentOnce daily post ocularOculi scientific advisory boardChief executive officerLeveraging oculiUnited statesRochester epidemiology projectOphthalmic surgical products market

Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter with Conference Call and Webcast Today at 4:30 p m ET

Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter with Conference Call and Webcast Today at 4:30 p m ET
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Jennifer vieraEnanta pharmaceuticals incExchange commissionInhibitor in developmentEnanta pharmaceuticalsDevelopment expenseDrug administrationReported positive topline dataL protein inhibitorOnce daily treatmentRespiratory syncytial virusInitiate phaseChallenge studyMarketable securities totaledChief executive officerThird quarter ended june

BioCryst Reports Second Quarter 2023 Financial Results and Provides Business Update

BioCryst Reports Second Quarter 2023 Financial Results and Provides Business Update
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesCharlie gayerJon stonehouseHelen thackrayJohn bluthExchange commissionProgram updatesResearch centerBiocryst pharmaceuticalsBiocryst pharmaceuticals incCryst reports second quarterProvides businessCryst pharmaceuticalsOnce daily treatmentHereditary angioedemaFinancial measures